TrialJournal of psychopharmacology (Oxford, England)2025

A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study).

R Hamish McAllister-Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.